UOC
CDLX icon

UBS O'Connor’s Cardlytics CDLX Stock Holding History

UBS O'Connor’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-45,000
Closed -$1.67M – 361
2024
Q4 		$1.67M Hold
45,000
– – 0.04% 179
2024
Q3 		$1.44M Sell
45,000
-29,478
-40% -$1.64M 0.04% 229
2024
Q2 		$6.11M Buy
74,478
+31,978
+75% +$3.46M 0.17% 84
2024
Q1 		$6.16M Buy
42,500
+22,500
+113% +$1.9M 0.18% 73
2023
Q4 		$1.84M Buy
+20,000
New +$2.03M 0.06% 183
2021
Q4 		– Sell
-6,500
Closed -$5.46M – 953
2021
Q3 		$5.46M Sell
6,500
-500
-7% -$507K 0.04% 206
2021
Q2 		$8.88M Hold
7,000
– – 0.08% 118
2021
Q1 		$7.68M Buy
+7,000
New +$9.24M 0.11% 121
2020
Q4 		– Sell
-3,000
Closed -$2.12M – 595
2020
Q3 		$2.12M Buy
+3,000
New +$2.18M 0.05% 178
2020
Q1 		– Sell
-1,000
Closed -$629K – 347
2019
Q4 		$629K Sell
1,000
-17,000
-94% -$8.31M 0.02% 248
2019
Q3 		$6.03M Sell
18,000
-16,435
-48% -$5.27M 0.17% 105
2019
Q2 		$8.95M Buy
+34,435
New +$6.9M 0.17% 83
2019
Q1 		– Sell
-15,000
Closed -$1.62M – 33
2018
Q4 		$1.62M Buy
+15,000
New +$2.53M 0.06% 148

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS O'Connor's CDLX Position: Q1 2025 in Review

UBS O'Connor sold out of Cardlytics (CDLX) in Q1 2025, closing a stake of 45,000 shares — an estimated $1.67M sold.

UBS O'Connor first reported a position in CDLX in Q4 2018 and held it in 13 quarters. The position peaked at $8.95M in Q2 2019. 108 funds tracked by Wall St. Rank hold CDLX as of Q1 2025.

  • UBS O'Connor reported no remaining Cardlytics position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 45,000 Cardlytics shares in Q1 2025, an estimated $1.67M.
  • UBS O'Connor first reported a position in Cardlytics in Q4 2018 and held it in 13 quarters.
  • UBS O'Connor's Cardlytics position peaked at $8.95M in Q2 2019.
  • 108 funds tracked by Wall St. Rank held Cardlytics as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.